Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapy
US-2024216388-A1 · Jul 4, 2024 · US
US9238803B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9238803-B2 |
| Application number | US-48615806-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 13, 2006 |
| Priority date | Jan 22, 2001 |
| Publication date | Jan 19, 2016 |
| Grant date | Jan 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are compositions and method comprising non-canonical (e.g., non-C2H2) zinc finger proteins.
Opening claim text (preview).
What is claimed is: 1. A non-naturally-occurring zinc-finger binding protein comprising a non-canonical zinc finger, wherein: said non-canonical zinc finger component comprises the sequence X 3 -Cys-X 2-4 -Cys-X 12 -His-X 1-7 -Z-X 4 (SEQ ID NO:121), where X is any amino acid, where Z is C, where residues 6 to 12 of X 12 are engineered to bind to a target nucleic acid sequence, wherein X 1-7 is selected from the group consisting of SETG (residues 2-5 of SEQ ID NO:12), LKSLTP (residues 2-7 of SEQ ID NO:13), SEN, VRI, KRS, KRL, LRW, ITT, IKG and IGG. 2. The non-naturally-occurring zinc-finger binding protein of claim 1 , wherein the target sequence is a promoter sequence. 3. The non-naturally-occurring zinc-finger binding protein of claim 1 , wherein the zinc finger binding protein comprises three zinc fingers. 4. The non-naturally-occurring zinc-finger binding protein of claim 3 , wherein the third zinc finger comprises a non-canonical zinc finger. 5. The non-naturally-occurring zinc-finger binding protein of claim 1 , further comprising a functional domain. 6. The non-naturally-occurring zinc-finger binding protein of claim 5 , wherein the functional domain is an endonuclease. 7. A plant cell comprising the non-naturally-occurring zinc-finger binding protein of claim 1 . 8. The non-naturally occurring zinc finger binding proteins of claim 5 , wherein the functional domain is a repressive domain. 9. The non-naturally occurring zinc finger binding proteins of claim 5 , wherein the functional domain is an activation domain.
containing a Zn-finger domain for DNA binding · CPC title
Methods for controlling, regulating or enhancing expression of transgenes in plant cells · CPC title
Methyltransferases (general) (2.1.1.) · CPC title
involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title
Regulators; Modulating activity · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.